(Q36385287)

13 August 2017

1 reference

title

Insights from molecular investigations of traditional Chinese herbal stroke medicines: implications for neuroprotective epilepsy therapy (English)

1 reference

13 August 2017

1

Nikolaus J Sucher

1 reference

13 August 2017

publication date

7 February 2006

1 reference

13 August 2017

1 reference

13 August 2017

volume

8

1 reference

13 August 2017

issue

2

1 reference

13 August 2017

page(s)

350-362

1 reference

Complementary and alternative medicine in neurology: hype, hope and hazards

13 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.11.015

The evolving role of natural products in drug discovery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.11.015

The influence of natural products upon drug discovery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.11.015

Natural products as sources of new drugs over the period 1981-2002.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.11.015

Progress in traditional Chinese medicine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.11.015

Traditional Chinese medicine: an approach to scientific proof and clinical validation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.11.015

Strategy for analysis and screening of bioactive compounds in traditional Chinese medicines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.11.015

Evolution of secondary metabolites from an ecological and molecular phylogenetic perspective

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.11.015

Stroke therapy in traditional Chinese medicine (TCM): prospects for drug discovery and development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.11.015

Pharmacological interventions for stroke: failures and future

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.11.015

Neuroprotective therapy for acute ischaemic stroke: down, but not out.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.11.015

7 January 2021

Treatments for stroke

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.11.015

Prolonged seizures and cellular injury: understanding the connection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.11.015

Epileptiform activity in rat hippocampus strengthens excitatory synapses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.11.015

Glutamate, GABA and epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.11.015

7 January 2021

Glutamate and epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.11.015

Cellular mechanisms underlying acquired epilepsy: the calcium hypothesis of the induction and maintainance of epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.11.015

The role of mammalian ionotropic receptors in synaptic plasticity: LTP, LTD and epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.11.015

Acupuncture: theory, efficacy, and practice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.11.015

Traditional Chinese herbal medicine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.11.015

Ethnobotany, phytochemistry and pharmacology of Uncaria (Rubiaceae).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.11.015

Neuroprotective herbs for stroke therapy in traditional eastern medicine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.11.015

Review of randomised controlled trials of traditional Chinese medicine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.11.015

Does Danshen improve disability after acute ischaemic stroke?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.11.015

Epilepsy in Chinese culture

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.11.015

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.11.015

Pathobiology of ischaemic stroke: an integrated view

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.11.015

Excitatory amino acids as a final common pathway for neurologic disorders.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.11.015

Mechanisms, challenges and opportunities in stroke

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.11.015

Apoptotic and antiapoptotic mechanisms in stroke.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.11.015

Glutamatergic mechanisms in schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.11.015

Clinical trials in neuroprotection. 23-25 January 2003, Key Biscayne, Florida, USA.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.11.015

Memantine is a clinically well tolerated N-methyl-D-aspartate (NMDA) receptor antagonist--a review of preclinical data

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.11.015

Extrasynaptic NMDARs oppose synaptic NMDARs by triggering CREB shut-off and cell death pathways

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.11.015

Turning down, but not off.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.11.015

N-methyl-D-aspartate receptor antagonist activity in traditional Chinese stroke medicines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.11.015

Magnesium as NMDA receptor blocker in the traditional Chinese medicine Danshen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.11.015

Efficacy of Choto-san on vascular dementia and the protective effect of the hooks and stems of Uncaria sinensis on glutamate-induced neuronal death

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.11.015

Protective effect of methanol extract of Uncaria rhynchophylla against excitotoxicity induced by N-methyl-D-aspartate in rat hippocampus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.11.015

Advances in chemistry and bioactivity of the genus Uncaria.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.11.015

Protective effect of phenolic compounds isolated from the hooks and stems of Uncaria sinensis on glutamate-induced neuronal death

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.11.015

Evaluation of the protective effects of alkaloids isolated from the hooks and stems of Uncaria sinensis on glutamate-induced neuronal death in cultured cerebellar granule cells from rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.11.015

Rhynchophylline and isorhynchophylline inhibit NMDA receptors expressed in Xenopus oocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.11.015

Proteomic analysis of NMDA receptor-adhesion protein signaling complexes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.11.015

A redox-based mechanism for the neuroprotective and neurodestructive effects of nitric oxide and related nitroso-compounds

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.11.015

Specific coupling of NMDA receptor activation to nitric oxide neurotoxicity by PSD-95 protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.11.015

Treatment of ischemic brain damage by perturbing NMDA receptor- PSD-95 protein interactions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.11.015

Flavonoids from Radix Scutellariae as potential stroke therapeutic agents by targeting the second postsynaptic density 95 (PSD-95)/disc large/zonula occludens-1 (PDZ) domain of PSD-95.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.11.015

Making protein interactions druggable: targeting PDZ domains

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.11.015

Advances in flavonoid research since 1992.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.11.015

Protective effects of baicalin on oxygen/glucose deprivation- and NMDA-induced injuries in rat hippocampal slices

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.11.015

Caspases as treatment targets in stroke and neurodegenerative diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.11.015

Induction of caspase-3-like protease may mediate delayed neuronal death in the hippocampus after transient cerebral ischemia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.11.015

Role of caspase-3 activation in cerebral ischemia-induced neurodegeneration in adult and neonatal brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.11.015

Combination of isoflurane and caspase inhibition reduces cerebral injury in rats subjected to focal cerebral ischemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.11.015

Caspase inhibitors reduce neuronal injury after focal but not global cerebral ischemia in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.11.015

Activation and cleavage of caspase-3 in apoptosis induced by experimental cerebral ischemia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.11.015

Caspase-3 activation after neonatal rat cerebral hypoxia-ischemia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.11.015

Caspase activation and neuroprotection in caspase-3- deficient mice after in vivo cerebral ischemia and in vitro oxygen glucose deprivation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.11.015

Prospects for caspase inhibitors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.11.015

Traditional Chinese medicines with caspase-inhibitory activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.11.015

PDZ domains and the organization of supramolecular complexes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.11.015

Network biology: understanding the cell's functional organization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.11.015

Evidence for dynamically organized modularity in the yeast protein-protein interaction network

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.11.015

Protein interaction networks from yeast to human

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.11.015

Assembly of Cell Regulatory Systems Through Protein Interaction Domains

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.11.015

Suppressive effects of isorhynchophylline on 5-HT2A receptor function in the brain: behavioural and electrophysiological studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.11.015

Magnesium for acute stroke (Intravenous Magnesium Efficacy in Stroke trial): randomised controlled trial.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.11.015

Further evolution toward effective therapy for acute ischemic stroke

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.11.015

Rationale and options for combination therapy in the treatment of Type 2 diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.11.015

Combination therapy as first-line treatment for hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.11.015

Medical therapy of epilepsy: when to initiate treatment and when to combine?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.11.015

The efficiency of multi-target drugs: the network approach might help drug design

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.11.015

Online research databases and journals of Chinese medicine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.11.015

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.YEBEH.2005.11.015

1 reference

13 August 2017

1 reference